ClinicalTrials.gov
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Related Articles
Current knowledge of vertebral osteomyelitis: a review
European Journal of Clinical Microbiology & Infectious Diseases – As life expectancy increases worldwide, the elderly population in every country is growing in both the…
Immunotherapy for Early-Stage Triple-Negative Breast Cancer | NEJM
Early-stage triple-negative breast cancers, which lack expression of three proteins (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2), have long been defined…
“Target Trial Emulation” for Observational Studies — Potential and Pitfalls | NEJM
To improve the quality of observational studies, target trial emulation requires careful specification of design elements, analytic methods for addressing confounding, and reporting of sensitivity…
Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies
This case series evaluates whether human leukocyte antigen (HLA) genotype could be inferred from standard next-generation sequencing, comparing concordance with confirmatory whole-exome sequencing and assessing…
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer | NEJM
In patients with early-stage triple-negative breast cancer, the phase 3 KEYNOTE-522 trial showed significant improvements in pathological complete response and event-free survival with the addition…
EARLY BIRD Black Friday 2024 is HERE!
We’re making Black Friday EVEN BETTER with a never before offered EARLY BIRD rate💗 10 Spots total First-come, first-served Offer disappears when all spots are…
Paper: Final Results from the Phase 2 Revive Study Investigating the Hepcidin Mimetic Rusfertide in Patients with Polycythemia Vera (PV)
Program: Oral and Poster Abstracts Session: 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III Hematology Disease Topics & Pathways: Research, Clinical trials, MPN, Drug development,…
Immunotherapy for Early-Stage Triple-Negative Breast Cancer | NEJM
Early-stage triple-negative breast cancers, which lack expression of three proteins (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2), have long been defined…
The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care | NEJM
Cancer research and care practices that adversely affect people with the Duffy null phenotype are an underrecognized and widespread source of discrimination against people of…
Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
We aimed to estimate vaccine effectiveness (VE) against COVID-19 mortality, and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks following…
